1-2 of 2
Tingting DU
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IMM01 Plus Tislelizumab in Prior Anti-PD-1 Failed Classic Hodgkin Lymphoma: An Open Label, Multicenter, Phase 2 Study (IMM01-04) Evaluating Safety As Well As Preliminary Anti-Tumor Activity

Keshu Zhou, Yuqin Song, Tienan Yi, Shuling Hou, Xingchen Liu, Ningjing Lin, Tingting Du, Xing Zhao, Xiaobo Wu, Xiwen Zhao, Wei Meng, Wencheng Xu, Qiying Lu, Wenzhi Tian, Jun Zhu
Journal: Blood
Blood (2023) 142 (Supplement 1): 609.
https://doi.org/10.1182/blood-2023-174829
Published: 2023
Journal Articles

Dynamic Single-Cell Profiling Reveals Novel Immune Regulatory Mechanism of ITK Inhibitor Soquelitinib in Refractory T Cell Lymphoma

Ning Ding, Yan Xie, Yong Guo, Kecheng Li, Tingting DU, Zhenjun Li, Yuejiao Li, Jiaowu Cao, Dingyao Hu, Lih-Yun Hsu, Richard Miller, Jun Zhu, Yuqin Song
Journal: Blood
Blood (2023) 142 (Supplement 1): 1442.
https://doi.org/10.1182/blood-2023-174421
Published: 2023